Home Ons netwerk Partners Okklo Life Sciences

Okklo Life Sciences

Okklo life sciences BV is a privately held biopharmaceutical company developing novel therapeutic solutions using cyclodextrin-based technologies. The current programs are focussed on lysosomal storage disorders and cardiovascular disorders.

The company was founded in December 2011 by a group of life-sciences experts previously involved in the development and approval of sugammadex (Bridion™), the first modified cyclodextrin marketed as a drug product.

We are continuously looking for collaborations and partnering opportunities with public and private partners - please visit our website to learn more about our technology platform strategy and development pipeline.

Bedrijfsgegevens

Bedrijfsnaam: Okklo Life Sciences BV
Website: http://www.okklo.com
Organisatietype: Bedrijf
Bezoekadres: Novio Tech Campus, gebouw M, Transistorweg 5R, 6534 AT Nijmegen
Postadres: Transistorweg 5, 6534 AT Nijmegen
KvK: 54153727

Maak connectie met Okklo Life Sciences


Social

Health Valley Partners

RSS 2.0 RSS 2.0 RSS 2.0